# The ARIES HeartMate 3 Pump IDE Study

Study · id `cardio:ct-nct04069156` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04069156](<https://clinicaltrials.gov/study/NCT04069156>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04069156

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 628 participants.

## Technical summary

Registry record NCT04069156. Randomized; quadruple masking; primary purpose supportive care. Start 2020-07-14 (actual); primary completion 2023-08-10 (actual). Results posted on 2025-03-27.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 628 participants (enrolled count; ClinicalTrials.gov record NCT04069156, source copy `cardio:ctgov-nct04069156-2025-03-27`, retrieved 2026-10-26)
- Started: 2020-07-14 (actual) (ClinicalTrials.gov record NCT04069156, source copy `cardio:ctgov-nct04069156-2025-03-27`, retrieved 2026-10-26)
- Primary completion: 2023-08-10 (actual) (ClinicalTrials.gov record NCT04069156, source copy `cardio:ctgov-nct04069156-2025-03-27`, retrieved 2026-10-26)
- Completion: 2023-08-10 (actual) (ClinicalTrials.gov record NCT04069156, source copy `cardio:ctgov-nct04069156-2025-03-27`, retrieved 2026-10-26)
- Results first posted: 2025-03-27 (ClinicalTrials.gov record NCT04069156, source copy `cardio:ctgov-nct04069156-2025-03-27`, retrieved 2026-10-26)
- Countries: United States; Australia; Austria; Canada; Czechia; France; Italy; Kazakhstan; United Kingdom (ClinicalTrials.gov record NCT04069156, source copy `cardio:ctgov-nct04069156-2025-03-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04069156-2025-03-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: The ARIES HeartMate 3 Pump IDE Study
- Condition: Heart Failure
- Intervention (Device): LVAD Implant
- Intervention (Drug): Aspirin 100mg
- Intervention (Drug): Placebo oral tablet
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device Therapy (`cardio:pubmed-40208135`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Hemocompatibility Outcomes With Pharmacological Therapy Following LVAD Implantation: Insights From the ARIES-HM3 Trial (`cardio:pubmed-41258850`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a56e6a55fa2f2dd9fe3edc5d6f19614b509095b3f630b1248b046198b8c6b834
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
